Through linking test results to electronic health records in England from 1995 to 2019, researchers estimated relative and absolute second primary cancer risks for BRCA1/2 carriers after breast cancer.
📊 This study gives us more generalizable information about cancer risks in BRCA carriers, which can help guide risk assessment and management.
Read the full article to learn more at: https://ascopubs.org/doi/10.1200/JCO.24.01146
Reference: Allen, et al. J Clin Oncol. 2024:JCO2401146. PMID: 39475295.